Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 ballot
Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
@prefix fhir: <http://hl7.org/fhir/> . @prefix owl: <http://www.w3.org/2002/07/owl#> . @prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . # - resource ------------------------------------------------------------------- a fhir:Composition ; fhir:nodeRole fhir:treeRoot ; fhir:id [ fhir:v "399871"] ; # fhir:meta [ fhir:versionId [ fhir:v "5" ] ; fhir:lastUpdated [ fhir:v "2025-12-11T20:35:21.032Z"^^xsd:dateTime ] ; ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-report"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-report> ] ) ] ; # fhir:language [ fhir:v "en"] ; # fhir:text [ fhir:status [ fhir:v "generated" ] ; fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\" xml:lang=\"en\" lang=\"en\"><p class=\"res-header-id\"><b>Generated Narrative: Composition 399871</b></p><a name=\"399871\"> </a><a name=\"hc399871\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 5; Last updated: 2025-12-11 20:35:21+0000; Language: en</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-report.html\">ParticipantFlowReport</a></p></div><p><b>url</b>: <a href=\"https://fevir.net/resources/Composition/399871\">https://fevir.net/resources/Composition/399871</a></p><p><b>identifier</b>: FEvIR Object Identifier/399871, FEvIR Linking Identifier/NCT03421379-participant-flow-report</p><p><b>status</b>: Final</p><p><b>type</b>: <span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowReport}\">Participant Flow Report</span></p><p><b>date</b>: 2025-12-11 20:35:21+0000</p><p><b>author</b>: [No author listed.]</p><p><b>title</b>: Participant Flow Report for NCT03421379</p><p><b>custodian</b>: <a href=\"Organization-118079.html\">Computable Publishing LLC</a></p><h3>RelatesTos</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Target[x]</b></td></tr><tr><td style=\"display: none\">*</td><td>Cite As</td><td><div><p>Participant Flow Report for NCT03421379 [Database Entry: FHIR Composition Resource]. Contributors: [No author listed.] [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 399871. Revised 2025-12-11. Available at: https://fevir.net/resources/Composition/399871. Computable resource at: https://fevir.net/resources/Composition/399871#json.</p>\n</div></td></tr></table><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Group #FG000</b></p><a name=\"399871/FG000\"> </a><a name=\"hc399871/FG000\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-exposure-group.html\">ExposureGroup</a></p></div><p><b>name</b>: NCT03421379 Flow Group Glucagon Nasal Powder/Glucagon Hydrochloride</p><p><b>description</b>: </p><div><p>A single dose of 3 milligram (mg) glucagon nasal powder was administered intranasally in period 1 then 1 mg single dose intramuscular glucagon hydrochloride solution was administered in period 2.</p>\n</div><p><b>type</b>: Person</p><p><b>membership</b>: Enumerated</p><h3>Characteristics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td><td><b>Exclude</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:\">Research Study from which this is a flow group</span></td><td>NCT03421379</td><td>false</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Group #FG001</b></p><a name=\"399871/FG001\"> </a><a name=\"hc399871/FG001\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-exposure-group.html\">ExposureGroup</a></p></div><p><b>name</b>: NCT03421379 Flow Group Glucagon Hydrochloride Solution/Glucagon Nasal Powder</p><p><b>description</b>: </p><div><p>A single dose of 1 mg glucagon hydrochloride solution was administered intramuscular (IM) in period 1 then 3 mg single dose glucagon nasal powder was administered in period 2.</p>\n</div><p><b>type</b>: Person</p><p><b>membership</b>: Enumerated</p><h3>Characteristics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td><td><b>Exclude</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:\">Research Study from which this is a flow group</span></td><td>NCT03421379</td><td>false</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-0-Period-1-group-FG000</b></p><a name=\"399871/NCT03421379-flow-milestone-0-Period-1-group-FG000\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-0-Period-1-group-FG000\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-0-Period-1-group-FG000</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - STARTED at Period 1</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG000\">Glucagon Nasal Powder/Glucagon Hydrochloride</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: STARTED at Period 1</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>34</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-0-Period-1-group-FG001</b></p><a name=\"399871/NCT03421379-flow-milestone-0-Period-1-group-FG001\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-0-Period-1-group-FG001\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-0-Period-1-group-FG001</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - STARTED at Period 1</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG001\">Glucagon Hydrochloride Solution/Glucagon Nasal Powder</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: STARTED at Period 1</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>41</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-1-Period-1-group-FG000</b></p><a name=\"399871/NCT03421379-flow-milestone-1-Period-1-group-FG000\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-1-Period-1-group-FG000\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-1-Period-1-group-FG000</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - Received at Least One Dose of Study Drug at Period 1</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG000\">Glucagon Nasal Powder/Glucagon Hydrochloride</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: Received at Least One Dose of Study Drug at Period 1</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>33</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-1-Period-1-group-FG001</b></p><a name=\"399871/NCT03421379-flow-milestone-1-Period-1-group-FG001\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-1-Period-1-group-FG001\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-1-Period-1-group-FG001</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - Received at Least One Dose of Study Drug at Period 1</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG001\">Glucagon Hydrochloride Solution/Glucagon Nasal Powder</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: Received at Least One Dose of Study Drug at Period 1</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>39</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-2-Period-1-group-FG000</b></p><a name=\"399871/NCT03421379-flow-milestone-2-Period-1-group-FG000\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-2-Period-1-group-FG000\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-2-Period-1-group-FG000</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - COMPLETED at Period 1</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG000\">Glucagon Nasal Powder/Glucagon Hydrochloride</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: COMPLETED at Period 1</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>32</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-2-Period-1-group-FG001</b></p><a name=\"399871/NCT03421379-flow-milestone-2-Period-1-group-FG001\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-2-Period-1-group-FG001\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-2-Period-1-group-FG001</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - COMPLETED at Period 1</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG001\">Glucagon Hydrochloride Solution/Glucagon Nasal Powder</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: COMPLETED at Period 1</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>37</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-3-Period-1-group-FG000</b></p><a name=\"399871/NCT03421379-flow-milestone-3-Period-1-group-FG000\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-3-Period-1-group-FG000\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-3-Period-1-group-FG000</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - NOT COMPLETED at Period 1</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG000\">Glucagon Nasal Powder/Glucagon Hydrochloride</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: NOT COMPLETED at Period 1</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>2</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-3-Period-1-group-FG001</b></p><a name=\"399871/NCT03421379-flow-milestone-3-Period-1-group-FG001\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-3-Period-1-group-FG001\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-3-Period-1-group-FG001</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - NOT COMPLETED at Period 1</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG001\">Glucagon Hydrochloride Solution/Glucagon Nasal Powder</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: NOT COMPLETED at Period 1</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>4</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-reason-Period-1-group-FG000</b></p><a name=\"399871/NCT03421379-flow-reason-Period-1-group-FG000\"> </a><a name=\"hc399871/NCT03421379-flow-reason-Period-1-group-FG000\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-reason-Period-1-group-FG000</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - Reasons for withdraw at Period 1</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG000\">Glucagon Nasal Powder/Glucagon Hydrochloride</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: Reasons for withdraw at Period 1</p></blockquote><blockquote><p><b>statistic</b></p><p><b>statisticType</b>: <span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></p><p><b>category</b>: <span title=\"Codes:\">Withdrawal by Subject</span></p><p><b>quantity</b>: 0</p></blockquote><blockquote><p><b>statistic</b></p><p><b>statisticType</b>: <span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></p><p><b>category</b>: <span title=\"Codes:\">Physician Decision</span></p><p><b>quantity</b>: 1</p></blockquote><blockquote><p><b>statistic</b></p><p><b>statisticType</b>: <span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></p><p><b>category</b>: <span title=\"Codes:\">Did not receive treatment</span></p><p><b>quantity</b>: 1</p></blockquote></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-reason-Period-1-group-FG001</b></p><a name=\"399871/NCT03421379-flow-reason-Period-1-group-FG001\"> </a><a name=\"hc399871/NCT03421379-flow-reason-Period-1-group-FG001\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-reason-Period-1-group-FG001</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - Reasons for withdraw at Period 1</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG001\">Glucagon Hydrochloride Solution/Glucagon Nasal Powder</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: Reasons for withdraw at Period 1</p></blockquote><blockquote><p><b>statistic</b></p><p><b>statisticType</b>: <span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></p><p><b>category</b>: <span title=\"Codes:\">Withdrawal by Subject</span></p><p><b>quantity</b>: 1</p></blockquote><blockquote><p><b>statistic</b></p><p><b>statisticType</b>: <span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></p><p><b>category</b>: <span title=\"Codes:\">Physician Decision</span></p><p><b>quantity</b>: 1</p></blockquote><blockquote><p><b>statistic</b></p><p><b>statisticType</b>: <span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></p><p><b>category</b>: <span title=\"Codes:\">Did not receive treatment</span></p><p><b>quantity</b>: 2</p></blockquote></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-0-Washout-Period--OPEN---3-to-1-FG000</b></p><a name=\"399871/NCT03421379-flow-milestone-0-Washout-Period--OPEN---3-to-1-FG000\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-0-Washout-Period--OPEN---3-to-1-FG000\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-0-Washout-Period--OPEN---3-to-1-FG000</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - STARTED at Washout Period (3 to 14 Days)</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG000\">Glucagon Nasal Powder/Glucagon Hydrochloride</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: STARTED at Washout Period (3 to 14 Days)</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>32</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-0-Washout-Period--OPEN---3-to-1-FG001</b></p><a name=\"399871/NCT03421379-flow-milestone-0-Washout-Period--OPEN---3-to-1-FG001\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-0-Washout-Period--OPEN---3-to-1-FG001\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-0-Washout-Period--OPEN---3-to-1-FG001</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - STARTED at Washout Period (3 to 14 Days)</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG001\">Glucagon Hydrochloride Solution/Glucagon Nasal Powder</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: STARTED at Washout Period (3 to 14 Days)</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>37</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-1-Washout-Period--OPEN---3-to-1-FG000</b></p><a name=\"399871/NCT03421379-flow-milestone-1-Washout-Period--OPEN---3-to-1-FG000\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-1-Washout-Period--OPEN---3-to-1-FG000\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-1-Washout-Period--OPEN---3-to-1-FG000</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - COMPLETED at Washout Period (3 to 14 Days)</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG000\">Glucagon Nasal Powder/Glucagon Hydrochloride</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: COMPLETED at Washout Period (3 to 14 Days)</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>32</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-1-Washout-Period--OPEN---3-to-1-FG001</b></p><a name=\"399871/NCT03421379-flow-milestone-1-Washout-Period--OPEN---3-to-1-FG001\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-1-Washout-Period--OPEN---3-to-1-FG001\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-1-Washout-Period--OPEN---3-to-1-FG001</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - COMPLETED at Washout Period (3 to 14 Days)</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG001\">Glucagon Hydrochloride Solution/Glucagon Nasal Powder</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: COMPLETED at Washout Period (3 to 14 Days)</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>37</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-2-Washout-Period--OPEN---3-to-1-FG000</b></p><a name=\"399871/NCT03421379-flow-milestone-2-Washout-Period--OPEN---3-to-1-FG000\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-2-Washout-Period--OPEN---3-to-1-FG000\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-2-Washout-Period--OPEN---3-to-1-FG000</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - NOT COMPLETED at Washout Period (3 to 14 Days)</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG000\">Glucagon Nasal Powder/Glucagon Hydrochloride</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: NOT COMPLETED at Washout Period (3 to 14 Days)</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>0</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-2-Washout-Period--OPEN---3-to-1-FG001</b></p><a name=\"399871/NCT03421379-flow-milestone-2-Washout-Period--OPEN---3-to-1-FG001\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-2-Washout-Period--OPEN---3-to-1-FG001\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-2-Washout-Period--OPEN---3-to-1-FG001</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - NOT COMPLETED at Washout Period (3 to 14 Days)</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG001\">Glucagon Hydrochloride Solution/Glucagon Nasal Powder</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: NOT COMPLETED at Washout Period (3 to 14 Days)</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>0</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-0-Period-2-group-FG000</b></p><a name=\"399871/NCT03421379-flow-milestone-0-Period-2-group-FG000\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-0-Period-2-group-FG000\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-0-Period-2-group-FG000</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - STARTED at Period 2</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG000\">Glucagon Nasal Powder/Glucagon Hydrochloride</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: STARTED at Period 2</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>32</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-0-Period-2-group-FG001</b></p><a name=\"399871/NCT03421379-flow-milestone-0-Period-2-group-FG001\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-0-Period-2-group-FG001\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-0-Period-2-group-FG001</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - STARTED at Period 2</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG001\">Glucagon Hydrochloride Solution/Glucagon Nasal Powder</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: STARTED at Period 2</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>37</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-1-Period-2-group-FG000</b></p><a name=\"399871/NCT03421379-flow-milestone-1-Period-2-group-FG000\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-1-Period-2-group-FG000\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-1-Period-2-group-FG000</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - COMPLETED at Period 2</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG000\">Glucagon Nasal Powder/Glucagon Hydrochloride</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: COMPLETED at Period 2</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>32</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-1-Period-2-group-FG001</b></p><a name=\"399871/NCT03421379-flow-milestone-1-Period-2-group-FG001\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-1-Period-2-group-FG001\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-1-Period-2-group-FG001</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - COMPLETED at Period 2</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG001\">Glucagon Hydrochloride Solution/Glucagon Nasal Powder</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: COMPLETED at Period 2</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>37</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-2-Period-2-group-FG000</b></p><a name=\"399871/NCT03421379-flow-milestone-2-Period-2-group-FG000\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-2-Period-2-group-FG000\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-2-Period-2-group-FG000</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - NOT COMPLETED at Period 2</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG000\">Glucagon Nasal Powder/Glucagon Hydrochloride</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: NOT COMPLETED at Period 2</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>0</td></tr></table></blockquote><hr/><blockquote><p class=\"res-header-id\"><b>Generated Narrative: Evidence #NCT03421379-flow-milestone-2-Period-2-group-FG001</b></p><a name=\"399871/NCT03421379-flow-milestone-2-Period-2-group-FG001\"> </a><a name=\"hc399871/NCT03421379-flow-milestone-2-Period-2-group-FG001\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-participant-flow-evidence.html\">ParticipantFlowEvidence</a></p></div><p><b>identifier</b>: FEvIR Linking Identifier/NCT03421379-flow-milestone-2-Period-2-group-FG001</p><p><b>title</b>: ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - NOT COMPLETED at Period 2</p><p><b>status</b>: Active</p><p><b>author</b>: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter: </p><h3>UseContexts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td><td><b>Value[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"CodeSystem-179423.html#179423-evidence-communication\">Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication</a> (Evidence Communication)</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 ParticipantFlowEvidence}\">ParticipantFlowEvidence</span></td></tr></table><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Population</p><p><b>observed</b>: <a href=\"#hc399871/FG001\">Glucagon Hydrochloride Solution/Glucagon Nasal Powder</a></p></blockquote><blockquote><p><b>variableDefinition</b></p><p><b>variableRole</b>: Outcome</p><p><b>observed</b>: NOT COMPLETED at Period 2</p></blockquote><h3>Statistics</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>StatisticType</b></td><td><b>Quantity</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/sevco STATO:0000047}\">Count</span></td><td>0</td></tr></table></blockquote></div>"^^rdf:XMLLiteral ] ] ; # fhir:contained ( [ a fhir:Group ; fhir:id [ fhir:v "FG000" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-group"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-group> ] ) ] ; fhir:name [ fhir:v "NCT03421379 Flow Group Glucagon Nasal Powder/Glucagon Hydrochloride" ] ; fhir:description [ fhir:v "A single dose of 3 milligram (mg) glucagon nasal powder was administered intranasally in period 1 then 1 mg single dose intramuscular glucagon hydrochloride solution was administered in period 2." ] ; fhir:type [ fhir:v "person" ] ; fhir:membership [ fhir:v "enumerated" ] ; ( fhir:characteristic [ fhir:code [ fhir:text [ fhir:v "Research Study from which this is a flow group" ] ] ; fhir:value [ a fhir:Reference ; fhir:display [ fhir:v "NCT03421379" ] ] ; fhir:exclude [ fhir:v false ] ] ) ] [ a fhir:Group ; fhir:id [ fhir:v "FG001" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-group"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-group> ] ) ] ; fhir:name [ fhir:v "NCT03421379 Flow Group Glucagon Hydrochloride Solution/Glucagon Nasal Powder" ] ; fhir:description [ fhir:v "A single dose of 1 mg glucagon hydrochloride solution was administered intramuscular (IM) in period 1 then 3 mg single dose glucagon nasal powder was administered in period 2." ] ; fhir:type [ fhir:v "person" ] ; fhir:membership [ fhir:v "enumerated" ] ; ( fhir:characteristic [ fhir:code [ fhir:text [ fhir:v "Research Study from which this is a flow group" ] ] ; fhir:value [ a fhir:Reference ; fhir:display [ fhir:v "NCT03421379" ] ] ; fhir:exclude [ fhir:v false ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-0-Period-1-group-FG000" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-0-Period-1-group-FG000" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - STARTED at Period 1" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG000> ; fhir:reference [ fhir:v "#FG000" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Nasal Powder/Glucagon Hydrochloride" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "STARTED at Period 1" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "34"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-0-Period-1-group-FG001" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-0-Period-1-group-FG001" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - STARTED at Period 1" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG001> ; fhir:reference [ fhir:v "#FG001" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Hydrochloride Solution/Glucagon Nasal Powder" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "STARTED at Period 1" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "41"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-1-Period-1-group-FG000" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-1-Period-1-group-FG000" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - Received at Least One Dose of Study Drug at Period 1" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG000> ; fhir:reference [ fhir:v "#FG000" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Nasal Powder/Glucagon Hydrochloride" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "Received at Least One Dose of Study Drug at Period 1" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "33"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-1-Period-1-group-FG001" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-1-Period-1-group-FG001" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - Received at Least One Dose of Study Drug at Period 1" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG001> ; fhir:reference [ fhir:v "#FG001" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Hydrochloride Solution/Glucagon Nasal Powder" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "Received at Least One Dose of Study Drug at Period 1" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "39"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-2-Period-1-group-FG000" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-2-Period-1-group-FG000" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - COMPLETED at Period 1" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG000> ; fhir:reference [ fhir:v "#FG000" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Nasal Powder/Glucagon Hydrochloride" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "COMPLETED at Period 1" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "32"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-2-Period-1-group-FG001" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-2-Period-1-group-FG001" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - COMPLETED at Period 1" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG001> ; fhir:reference [ fhir:v "#FG001" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Hydrochloride Solution/Glucagon Nasal Powder" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "COMPLETED at Period 1" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "37"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-3-Period-1-group-FG000" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-3-Period-1-group-FG000" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - NOT COMPLETED at Period 1" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG000> ; fhir:reference [ fhir:v "#FG000" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Nasal Powder/Glucagon Hydrochloride" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "NOT COMPLETED at Period 1" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "2"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-3-Period-1-group-FG001" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-3-Period-1-group-FG001" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - NOT COMPLETED at Period 1" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG001> ; fhir:reference [ fhir:v "#FG001" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Hydrochloride Solution/Glucagon Nasal Powder" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "NOT COMPLETED at Period 1" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "4"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-reason-Period-1-group-FG000" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-reason-Period-1-group-FG000" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - Reasons for withdraw at Period 1" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG000> ; fhir:reference [ fhir:v "#FG000" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Nasal Powder/Glucagon Hydrochloride" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "Reasons for withdraw at Period 1" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:category [ fhir:text [ fhir:v "Withdrawal by Subject" ] ] ; fhir:quantity [ fhir:value [ fhir:v "0"^^xsd:decimal ] ] ] [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:category [ fhir:text [ fhir:v "Physician Decision" ] ] ; fhir:quantity [ fhir:value [ fhir:v "1"^^xsd:decimal ] ] ] [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:category [ fhir:text [ fhir:v "Did not receive treatment" ] ] ; fhir:quantity [ fhir:value [ fhir:v "1"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-reason-Period-1-group-FG001" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-reason-Period-1-group-FG001" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - Reasons for withdraw at Period 1" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG001> ; fhir:reference [ fhir:v "#FG001" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Hydrochloride Solution/Glucagon Nasal Powder" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "Reasons for withdraw at Period 1" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:category [ fhir:text [ fhir:v "Withdrawal by Subject" ] ] ; fhir:quantity [ fhir:value [ fhir:v "1"^^xsd:decimal ] ] ] [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:category [ fhir:text [ fhir:v "Physician Decision" ] ] ; fhir:quantity [ fhir:value [ fhir:v "1"^^xsd:decimal ] ] ] [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:category [ fhir:text [ fhir:v "Did not receive treatment" ] ] ; fhir:quantity [ fhir:value [ fhir:v "2"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-0-Washout-Period--OPEN---3-to-1-FG000" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-0-Washout-Period--OPEN---3-to-1-FG000" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - STARTED at Washout Period (3 to 14 Days)" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG000> ; fhir:reference [ fhir:v "#FG000" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Nasal Powder/Glucagon Hydrochloride" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "STARTED at Washout Period (3 to 14 Days)" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "32"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-0-Washout-Period--OPEN---3-to-1-FG001" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-0-Washout-Period--OPEN---3-to-1-FG001" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - STARTED at Washout Period (3 to 14 Days)" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG001> ; fhir:reference [ fhir:v "#FG001" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Hydrochloride Solution/Glucagon Nasal Powder" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "STARTED at Washout Period (3 to 14 Days)" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "37"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-1-Washout-Period--OPEN---3-to-1-FG000" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-1-Washout-Period--OPEN---3-to-1-FG000" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - COMPLETED at Washout Period (3 to 14 Days)" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG000> ; fhir:reference [ fhir:v "#FG000" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Nasal Powder/Glucagon Hydrochloride" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "COMPLETED at Washout Period (3 to 14 Days)" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "32"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-1-Washout-Period--OPEN---3-to-1-FG001" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-1-Washout-Period--OPEN---3-to-1-FG001" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - COMPLETED at Washout Period (3 to 14 Days)" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG001> ; fhir:reference [ fhir:v "#FG001" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Hydrochloride Solution/Glucagon Nasal Powder" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "COMPLETED at Washout Period (3 to 14 Days)" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "37"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-2-Washout-Period--OPEN---3-to-1-FG000" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-2-Washout-Period--OPEN---3-to-1-FG000" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - NOT COMPLETED at Washout Period (3 to 14 Days)" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG000> ; fhir:reference [ fhir:v "#FG000" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Nasal Powder/Glucagon Hydrochloride" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "NOT COMPLETED at Washout Period (3 to 14 Days)" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "0"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-2-Washout-Period--OPEN---3-to-1-FG001" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-2-Washout-Period--OPEN---3-to-1-FG001" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - NOT COMPLETED at Washout Period (3 to 14 Days)" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG001> ; fhir:reference [ fhir:v "#FG001" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Hydrochloride Solution/Glucagon Nasal Powder" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "NOT COMPLETED at Washout Period (3 to 14 Days)" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "0"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-0-Period-2-group-FG000" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-0-Period-2-group-FG000" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - STARTED at Period 2" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG000> ; fhir:reference [ fhir:v "#FG000" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Nasal Powder/Glucagon Hydrochloride" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "STARTED at Period 2" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "32"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-0-Period-2-group-FG001" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-0-Period-2-group-FG001" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - STARTED at Period 2" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG001> ; fhir:reference [ fhir:v "#FG001" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Hydrochloride Solution/Glucagon Nasal Powder" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "STARTED at Period 2" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "37"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-1-Period-2-group-FG000" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-1-Period-2-group-FG000" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - COMPLETED at Period 2" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG000> ; fhir:reference [ fhir:v "#FG000" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Nasal Powder/Glucagon Hydrochloride" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "COMPLETED at Period 2" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "32"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-1-Period-2-group-FG001" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-1-Period-2-group-FG001" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - COMPLETED at Period 2" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG001> ; fhir:reference [ fhir:v "#FG001" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Hydrochloride Solution/Glucagon Nasal Powder" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "COMPLETED at Period 2" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "37"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-2-Period-2-group-FG000" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-2-Period-2-group-FG000" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - NOT COMPLETED at Period 2" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG000> ; fhir:reference [ fhir:v "#FG000" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Nasal Powder/Glucagon Hydrochloride" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "NOT COMPLETED at Period 2" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "0"^^xsd:decimal ] ] ] ) ] [ a fhir:Evidence ; fhir:id [ fhir:v "NCT03421379-flow-milestone-2-Period-2-group-FG001" ] ; fhir:meta [ ( fhir:profile [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence"^^xsd:anyURI ; fhir:l <http://hl7.org/fhir/uv/ebm/StructureDefinition/participant-flow-evidence> ] ) ] ; ( fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-flow-milestone-2-Period-2-group-FG001" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; fhir:title [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - NOT COMPLETED at Period 2" ] ; fhir:status [ fhir:v "active" ] ; ( fhir:author [ fhir:name [ fhir:v "Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter" ] ] ) ; ( fhir:useContext [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowEvidence" ] ; fhir:display [ fhir:v "ParticipantFlowEvidence" ] ] ) ] ] ) ; ( fhir:variableDefinition [ fhir:variableRole [ fhir:v "population" ] ; fhir:observed [ fhir:l <#FG001> ; fhir:reference [ fhir:v "#FG001" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Hydrochloride Solution/Glucagon Nasal Powder" ] ] ] [ fhir:variableRole [ fhir:v "outcome" ] ; fhir:observed [ fhir:display [ fhir:v "NOT COMPLETED at Period 2" ] ] ] ) ; ( fhir:statistic [ fhir:statisticType [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/sevco"^^xsd:anyURI ; fhir:l <https://fevir.net/sevco> ] ; fhir:code [ fhir:v "STATO:0000047" ] ; fhir:display [ fhir:v "Count" ] ] ) ] ; fhir:quantity [ fhir:value [ fhir:v "0"^^xsd:decimal ] ] ] ) ] ) ; # fhir:url [ fhir:v "https://fevir.net/resources/Composition/399871"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/Composition/399871> ] ; # fhir:identifier ( [ fhir:type [ ( fhir:coding [ fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/v2-0203"^^xsd:anyURI ; fhir:l <http://terminology.hl7.org/CodeSystem/v2-0203> ] ; fhir:code [ fhir:v "ACSN" ] ; fhir:display [ fhir:v "Accession ID" ] ] ) ; fhir:text [ fhir:v "FEvIR Object Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FOI"^^xsd:anyURI ; fhir:l <https://fevir.net/FOI> ] ; fhir:value [ fhir:v "399871" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l <https://fevir.net/FLI> ] ; fhir:value [ fhir:v "NCT03421379-participant-flow-report" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; # fhir:status [ fhir:v "final"] ; # fhir:type [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "ParticipantFlowReport" ] ; fhir:display [ fhir:v "ParticipantFlowReport" ] ] ) ; fhir:text [ fhir:v "Participant Flow Report" ] ] ; # fhir:date [ fhir:v "2025-12-11T20:35:21.032Z"^^xsd:dateTime] ; # fhir:author ( [ fhir:display [ fhir:v "[No author listed.]" ] ] ) ; # fhir:title [ fhir:v "Participant Flow Report for NCT03421379"] ; # fhir:custodian [ fhir:l fhir:Organization/118079 ; fhir:reference [ fhir:v "Organization/118079" ] ; fhir:type [ fhir:v "Organization"^^xsd:anyURI ; fhir:l fhir:Organization ] ; fhir:display [ fhir:v "Computable Publishing LLC" ] ] ; # fhir:relatesTo ( [ fhir:type [ fhir:v "cite-as" ] ; fhir:target [ a fhir:Markdown ; fhir:v "Participant Flow Report for NCT03421379 [Database Entry: FHIR Composition Resource]. Contributors: [No author listed.] [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 399871. Revised 2025-12-11. Available at: https://fevir.net/resources/Composition/399871. Computable resource at: https://fevir.net/resources/Composition/399871#json." ] ] ) ; # fhir:section ( [ fhir:title [ fhir:v "Flow PreAssignment Details" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "participant-flow-details" ] ; fhir:display [ fhir:v "Participant Flow Details" ] ] ) ; fhir:text [ fhir:v "FlowPreAssignmentDetails" ] ] ; fhir:text [ fhir:status [ fhir:v "generated" ] ; fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\">Participants were randomized to receive either nasal glucagon or intramuscular (IM) glucagon in the first period, followed by the alternate treatment in the second period.</div>"^^rdf:XMLLiteral ] ] ] [ fhir:title [ fhir:v "Flow Group List" ] ; fhir:code [ fhir:text [ fhir:v "FlowGroupList" ] ] ; fhir:text [ fhir:status [ fhir:v "generated" ] ; fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\">Glucagon Nasal Powder/Glucagon Hydrochloride, Glucagon Hydrochloride Solution/Glucagon Nasal Powder</div>"^^rdf:XMLLiteral ] ] ; ( fhir:entry [ fhir:l <#FG000> ; fhir:reference [ fhir:v "#FG000" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Nasal Powder/Glucagon Hydrochloride" ] ] [ fhir:l <#FG001> ; fhir:reference [ fhir:v "#FG001" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:display [ fhir:v "Glucagon Hydrochloride Solution/Glucagon Nasal Powder" ] ] ) ] [ fhir:title [ fhir:v "STARTED at Period 1" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "results" ] ; fhir:display [ fhir:v "Results" ] ] ) ; fhir:text [ fhir:v "Participant Flow Results" ] ] ; fhir:focus [ fhir:display [ fhir:v "STARTED at Period 1" ] ] ; fhir:text [ fhir:status [ fhir:v "empty" ] ; fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"^^rdf:XMLLiteral ] ] ; ( fhir:entry [ fhir:l <#NCT03421379-flow-milestone-0-Period-1-group-FG000> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-0-Period-1-group-FG000" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - STARTED at Period 1" ] ] [ fhir:l <#NCT03421379-flow-milestone-0-Period-1-group-FG001> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-0-Period-1-group-FG001" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - STARTED at Period 1" ] ] ) ] [ fhir:title [ fhir:v "Received at Least One Dose of Study Drug at Period 1" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "results" ] ; fhir:display [ fhir:v "Results" ] ] ) ; fhir:text [ fhir:v "Participant Flow Results" ] ] ; fhir:focus [ fhir:display [ fhir:v "Received at Least One Dose of Study Drug at Period 1" ] ] ; fhir:text [ fhir:status [ fhir:v "empty" ] ; fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"^^rdf:XMLLiteral ] ] ; ( fhir:entry [ fhir:l <#NCT03421379-flow-milestone-1-Period-1-group-FG000> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-1-Period-1-group-FG000" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - Received at Least One Dose of Study Drug at Period 1" ] ] [ fhir:l <#NCT03421379-flow-milestone-1-Period-1-group-FG001> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-1-Period-1-group-FG001" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - Received at Least One Dose of Study Drug at Period 1" ] ] ) ] [ fhir:title [ fhir:v "COMPLETED at Period 1" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "results" ] ; fhir:display [ fhir:v "Results" ] ] ) ; fhir:text [ fhir:v "Participant Flow Results" ] ] ; fhir:focus [ fhir:display [ fhir:v "COMPLETED at Period 1" ] ] ; fhir:text [ fhir:status [ fhir:v "empty" ] ; fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"^^rdf:XMLLiteral ] ] ; ( fhir:entry [ fhir:l <#NCT03421379-flow-milestone-2-Period-1-group-FG000> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-2-Period-1-group-FG000" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - COMPLETED at Period 1" ] ] [ fhir:l <#NCT03421379-flow-milestone-2-Period-1-group-FG001> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-2-Period-1-group-FG001" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - COMPLETED at Period 1" ] ] ) ] [ fhir:title [ fhir:v "NOT COMPLETED at Period 1" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "results" ] ; fhir:display [ fhir:v "Results" ] ] ) ; fhir:text [ fhir:v "Participant Flow Results" ] ] ; fhir:focus [ fhir:display [ fhir:v "NOT COMPLETED at Period 1" ] ] ; fhir:text [ fhir:status [ fhir:v "empty" ] ; fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"^^rdf:XMLLiteral ] ] ; ( fhir:entry [ fhir:l <#NCT03421379-flow-milestone-3-Period-1-group-FG000> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-3-Period-1-group-FG000" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - NOT COMPLETED at Period 1" ] ] [ fhir:l <#NCT03421379-flow-milestone-3-Period-1-group-FG001> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-3-Period-1-group-FG001" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - NOT COMPLETED at Period 1" ] ] ) ] [ fhir:title [ fhir:v "Reasons for withdraw at Period 1" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "results" ] ; fhir:display [ fhir:v "Results" ] ] ) ; fhir:text [ fhir:v "Participant Flow Results" ] ] ; fhir:focus [ fhir:display [ fhir:v "Reasons for withdraw at Period 1" ] ] ; fhir:text [ fhir:status [ fhir:v "empty" ] ; fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"^^rdf:XMLLiteral ] ] ; ( fhir:entry [ fhir:l <#NCT03421379-flow-reason-Period-1-group-FG000> ; fhir:reference [ fhir:v "#NCT03421379-flow-reason-Period-1-group-FG000" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - Reasons for withdraw at Period 1" ] ] [ fhir:l <#NCT03421379-flow-reason-Period-1-group-FG001> ; fhir:reference [ fhir:v "#NCT03421379-flow-reason-Period-1-group-FG001" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - Reasons for withdraw at Period 1" ] ] ) ] [ fhir:title [ fhir:v "STARTED at Washout Period (3 to 14 Days)" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "results" ] ; fhir:display [ fhir:v "Results" ] ] ) ; fhir:text [ fhir:v "Participant Flow Results" ] ] ; fhir:focus [ fhir:display [ fhir:v "STARTED at Washout Period (3 to 14 Days)" ] ] ; fhir:text [ fhir:status [ fhir:v "empty" ] ; fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"^^rdf:XMLLiteral ] ] ; ( fhir:entry [ fhir:l <#NCT03421379-flow-milestone-0-Washout-Period--OPEN---3-to-1-FG000> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-0-Washout-Period--OPEN---3-to-1-FG000" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - STARTED at Washout Period (3 to 14 Days)" ] ] [ fhir:l <#NCT03421379-flow-milestone-0-Washout-Period--OPEN---3-to-1-FG001> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-0-Washout-Period--OPEN---3-to-1-FG001" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - STARTED at Washout Period (3 to 14 Days)" ] ] ) ] [ fhir:title [ fhir:v "COMPLETED at Washout Period (3 to 14 Days)" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "results" ] ; fhir:display [ fhir:v "Results" ] ] ) ; fhir:text [ fhir:v "Participant Flow Results" ] ] ; fhir:focus [ fhir:display [ fhir:v "COMPLETED at Washout Period (3 to 14 Days)" ] ] ; fhir:text [ fhir:status [ fhir:v "empty" ] ; fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"^^rdf:XMLLiteral ] ] ; ( fhir:entry [ fhir:l <#NCT03421379-flow-milestone-1-Washout-Period--OPEN---3-to-1-FG000> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-1-Washout-Period--OPEN---3-to-1-FG000" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - COMPLETED at Washout Period (3 to 14 Days)" ] ] [ fhir:l <#NCT03421379-flow-milestone-1-Washout-Period--OPEN---3-to-1-FG001> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-1-Washout-Period--OPEN---3-to-1-FG001" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - COMPLETED at Washout Period (3 to 14 Days)" ] ] ) ] [ fhir:title [ fhir:v "NOT COMPLETED at Washout Period (3 to 14 Days)" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "results" ] ; fhir:display [ fhir:v "Results" ] ] ) ; fhir:text [ fhir:v "Participant Flow Results" ] ] ; fhir:focus [ fhir:display [ fhir:v "NOT COMPLETED at Washout Period (3 to 14 Days)" ] ] ; fhir:text [ fhir:status [ fhir:v "empty" ] ; fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"^^rdf:XMLLiteral ] ] ; ( fhir:entry [ fhir:l <#NCT03421379-flow-milestone-2-Washout-Period--OPEN---3-to-1-FG000> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-2-Washout-Period--OPEN---3-to-1-FG000" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - NOT COMPLETED at Washout Period (3 to 14 Days)" ] ] [ fhir:l <#NCT03421379-flow-milestone-2-Washout-Period--OPEN---3-to-1-FG001> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-2-Washout-Period--OPEN---3-to-1-FG001" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - NOT COMPLETED at Washout Period (3 to 14 Days)" ] ] ) ] [ fhir:title [ fhir:v "STARTED at Period 2" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "results" ] ; fhir:display [ fhir:v "Results" ] ] ) ; fhir:text [ fhir:v "Participant Flow Results" ] ] ; fhir:focus [ fhir:display [ fhir:v "STARTED at Period 2" ] ] ; fhir:text [ fhir:status [ fhir:v "empty" ] ; fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"^^rdf:XMLLiteral ] ] ; ( fhir:entry [ fhir:l <#NCT03421379-flow-milestone-0-Period-2-group-FG000> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-0-Period-2-group-FG000" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - STARTED at Period 2" ] ] [ fhir:l <#NCT03421379-flow-milestone-0-Period-2-group-FG001> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-0-Period-2-group-FG001" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - STARTED at Period 2" ] ] ) ] [ fhir:title [ fhir:v "COMPLETED at Period 2" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "results" ] ; fhir:display [ fhir:v "Results" ] ] ) ; fhir:text [ fhir:v "Participant Flow Results" ] ] ; fhir:focus [ fhir:display [ fhir:v "COMPLETED at Period 2" ] ] ; fhir:text [ fhir:status [ fhir:v "empty" ] ; fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"^^rdf:XMLLiteral ] ] ; ( fhir:entry [ fhir:l <#NCT03421379-flow-milestone-1-Period-2-group-FG000> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-1-Period-2-group-FG000" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - COMPLETED at Period 2" ] ] [ fhir:l <#NCT03421379-flow-milestone-1-Period-2-group-FG001> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-1-Period-2-group-FG001" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - COMPLETED at Period 2" ] ] ) ] [ fhir:title [ fhir:v "NOT COMPLETED at Period 2" ] ; fhir:code [ ( fhir:coding [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l <https://fevir.net/resources/CodeSystem/179423> ] ; fhir:code [ fhir:v "results" ] ; fhir:display [ fhir:v "Results" ] ] ) ; fhir:text [ fhir:v "Participant Flow Results" ] ] ; fhir:focus [ fhir:display [ fhir:v "NOT COMPLETED at Period 2" ] ] ; fhir:text [ fhir:status [ fhir:v "empty" ] ; fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>[No data.]</p></div>"^^rdf:XMLLiteral ] ] ; ( fhir:entry [ fhir:l <#NCT03421379-flow-milestone-2-Period-2-group-FG000> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-2-Period-2-group-FG000" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Nasal Powder/Glucagon Hydrochloride - NOT COMPLETED at Period 2" ] ] [ fhir:l <#NCT03421379-flow-milestone-2-Period-2-group-FG001> ; fhir:reference [ fhir:v "#NCT03421379-flow-milestone-2-Period-2-group-FG001" ] ; fhir:type [ fhir:v "Evidence"^^xsd:anyURI ; fhir:l fhir:Evidence ] ; fhir:display [ fhir:v "ParticipantFlowEvidence: NCT03421379 Glucagon Hydrochloride Solution/Glucagon Nasal Powder - NOT COMPLETED at Period 2" ] ] ) ] ) . #
IG © 2024+ HL7 International / Clinical Decision Support.
Package hl7.fhir.uv.ebm#1.0.0-ballot3 based on FHIR 6.0.0-ballot3.
Generated
2026-01-07
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change